arrow
O

Onima Chowdhury

Oxford University Hospitals NHS Foundation Trust
H指数:12
被引数:1,539

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI)

开发用于评估VEXAS综合征(VEXAS-DAI)疾病活动度的指数

2026-09-080
OAAI
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome

PAXIS:一项随机、双盲、安慰剂对照、剂量探索的II期研究(第一部分),随后进行开放标签期(第二部分),以评估Pacritinib在VEXAS综合征患者中的有效性和安全性

2026-02-270
OAAI
Establishing a consensus definition of VEXAS flare for clinical research

建立VEXAS flare的临床研究共识定义

2025-12-010
PRE
Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study

VEXAS综合征患者治疗效果:一项回顾性队列研究

2025-05-210
OA
Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide
LEUKEMIA
IF13.4
2020-08-078
OAAI
Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferation
2017-06-2144
OAAI